PITTSBURGH & NEW YORK--(BUSINESS WIRE)--Aug. 29, 2006--invivodata(R) inc., the industry leader in patient reported outcomes (PRO) solutions for clinical research, and Medidata Solutions, a global provider of electronic clinical data capture, management and reporting solutions, today announced the first integration of data from invivodata’s DiaryPRO(TM) handheld electronic patient diary with Medidata’s Rave(TM) electronic clinical data management platform. This solution is being used by Nabi Biopharmaceuticals in a Phase IIb proof-of-concept clinical trial for NicVAX, a vaccine candidate for nicotine addiction.
